Cargando…
End-to-End Platform for Human Pluripotent Stem Cell Manufacturing
Industrialization of stem-cell based therapies requires innovative solutions to close the gap between research and commercialization. Scalable cell production platforms are needed to reliably deliver the cell quantities needed during the various stages of development and commercial supply. Human plu...
Autores principales: | Pandey, Puspa R., Tomney, Amarel, Woon, Marites T., Uth, Nicholas, Shafighi, Farjad, Ngabo, Igor, Vallabhaneni, Haritha, Levinson, Yonatan, Abraham, Eytan, Friedrich Ben-Nun, Inbar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981419/ https://www.ncbi.nlm.nih.gov/pubmed/31877727 http://dx.doi.org/10.3390/ijms21010089 |
Ejemplares similares
-
Enabling Allogeneic T Cell-Based Therapies: Scalable Stirred-Tank Bioreactor Mediated Manufacturing
por: Gatla, Himavanth, et al.
Publicado: (2022) -
MUC5B induces in vitro neutrophil extracellular trap formation: Implication in otitis media
por: Val, Stéphanie, et al.
Publicado: (2020) -
Coil-end design and end-spacer manufacture
por: Russenschuck, Stephan
Publicado: (1999) -
End‐to‐end collaboration to transform biopharmaceutical development and manufacturing
por: Erickson, John, et al.
Publicado: (2021) -
A general end-to-end diagnosis framework for manufacturing systems
por: Yuan, Ye, et al.
Publicado: (2020)